or Try an Advanced Search...

    ETF Components for XPH - SPDR S&P Pharmaceuticals ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    CORT B -2.76 4.32
    LBPH A -0.05 4.15
    BMY A -2.60 3.75
    EWTX B 1.28 3.64
    ITCI A 2.11 3.49
    CTLT D 0.22 3.47
    JAZZ D 0.38 3.46
    JNJ D 0.17 3.44
    RPRX D 0.37 3.43
    VTRS B 0.17 3.43
    PFE D -0.74 3.41
    LLY F -1.30 3.36
    ZTS D 1.77 3.31
    AXSM C -0.21 3.30
    MRK F -0.43 3.18
    PRGO D 1.79 3.15
    ELAN D -0.32 2.98
    OGN D -3.78 2.93
    ARVN C 1.78 2.76
    SAVA D 1.57 2.70
    TARS A 6.32 2.36
    AMPH A 0.40 2.25
    PBH A 0.41 2.22
    SUPN B -0.29 2.03
    PCRX C -0.18 2.01
    LGND A 4.11 1.72
    COLL F -1.99 1.69
    OCUL B -1.33 1.59
    ANIP F 1.65 1.57
    HROW C 1.29 1.46
    HRMY D 2.96 1.27
    AMRX B 1.00 1.24
    WVE B 0.88 1.16
    INVA C -1.53 1.02
    LQDA C 1.20 0.99
    PLRX A 3.20 0.93
    MNMD C -2.54 0.90
    EYPT C 2.55 0.87
    PHAT B 6.53 0.87
    FULC F 1.58 0.83
    ELVN B -0.79 0.75
    EOLS A 2.63 0.70
    NUVB F 4.07 0.49
    XERS A 0.31 0.49

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Pharmaceutical Medicine Pharmaceutical Products Pain S&P 500 Alzheimer's Disease Animal Health Life Sciences Biotechnology Depression Diabetes Disease Drugs Hypertension Medication Neuroscience Pharmacology Suspension Acid
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

    Recent News for SPDR S&P Pharmaceuticals ETF & its Holdings

    Date Stock Title
    Nov 2 ITCI Here's What Analysts Are Forecasting For Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) After Its Third-Quarter Results
    Nov 1 LLY Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and Additional Results from Its Breast Cancer Portfolio at the San Antonio Breast Cancer Symposium
    Nov 1 LLY Market Volatility Soars Ahead Of Elections, Tech Earnings Mixed, Strikes And Hurricanes Knock Employment Down: This Week In The Markets
    Nov 1 LLY Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
    Nov 1 ZTS Zoetis Q3 2024 Earnings Preview
    Nov 1 JNJ Stocks that hedge funds moved from long to short in August - Jefferies
    Nov 1 BMY Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade
    Nov 1 LLY Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
    Nov 1 PFE Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
    Nov 1 MRK Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
    Nov 1 ZTS Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
    Nov 1 LLY Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
    Nov 1 CORT Earnings Estimates Moving Higher for Corcept (CORT): Time to Buy?
    Nov 1 HRMY Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
    Nov 1 OGN Organon Third Quarter 2024 Earnings: EPS: US$1.39 (vs US$0.23 in 3Q 2023)
    Nov 1 LLY Hims & Hers Health Faces Pressure Ahead of Earnings Amid Eli Lilly's GLP-1 News
    Nov 1 BMY Bristol Myers posts long-term Phase 3 data for schizophrenia drug Cobenfy
    Nov 1 PFE 3 Reasons Relying on Social Security Alone Could be a Risk. And 3 Stocks to Invest in Today.
    Nov 1 LQDA Will Y-mAbs Therapeutics, Inc. (YMAB) Report Negative Earnings Next Week? What You Should Know
    Nov 1 ANIP Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment
    Back to the Main XPH Page...